Egis Pharmaceuticals PLC

Egis is an EU-based, vertically integrated generic pharmaceutical company with over 110 years of experience across the entire value chain. Renowned for reliable supply, proprietary technologies, and a broad EU-GMP portfolio, Egis delivers high-quality medicines to over 100 countries. Its 500+ strong R&D team drives innovation across cardiovascular, CNS, and oncology segments, with a key focus on cardiometabolic therapies and fixed-dose combinations (FDCs). Egis also supports partners with robust API capabilities and dependable contract development and manufacturing services.